Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage

Open access
Chen, Yan‐Mei, Zheng, Yuanting, Yu, Ying, Wang, Yunzhi, Huang, Qingxia, Qian, Feng, Sun, Lei, Song, Zhi‐Gang, Chen, Ziyin, Feng, Jinwen, An, Yanpeng, Yang, Jingcheng, Su, Zhenqiang, Sun, Shanyue, Dai, Fahui, Chen, Qinsheng, Lu, Qinwei, Li, Pengcheng, Ling, Yun, Yang, Zhong, Tang, Huiru, Shi, Leming, Jin, Li, Holmes, Edward C, Ding, Chen, Zhu, Tong‐Yu, Zhang, Yong‐Zhen · 2020 · The EMBO Journal

Abstract

COVID‐19 is characterized by dysregulated immune responses, metabolic dysfunction and adverse effects on the function of multiple organs. To understand host responses to COVID‐19 pathophysiology, we combined transcriptomics, proteomics, and metabolomics to identify molecular markers in peripheral blood and plasma samples of 66 COVID‐19‐infected patients experiencing a range of disease severities and 17 healthy controls. A large number of expressed genes, proteins, metabolites, and extracellular RNAs (exRNAs) exhibit strong associations with various clinical parameters. Multiple sets of tissue‐specific proteins and exRNAs varied significantly in both mild and severe patients suggesting a potential impact on tissue function. Chronic activation of neutrophils, IFN‐I signaling, and a high level of inflammatory cytokines were observed in patients with severe disease progression. In contrast, COVID‐19‐infected patients experiencing milder disease symptoms showed robust T‐cell responses. Finally, we identified genes, proteins, and exRNAs as potential biomarkers that might assist in predicting the prognosis of SARS‐CoV‐2 infection. These data refine our understanding of the pathophysiology and clinical progress of COVID‐19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2020105896

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 187

Metadata

Authors
Chen, Y., Zheng, Y., Yu, Y., Wang, Y., Huang, Q., Qian, F., Sun, L., Song, Z., Chen, Z., Feng, J., An, Y., Yang, J., Su, Z., Sun, S., Dai, F., Chen, Q., Lu, Q., Li, P., Ling, Y., Yang, Z., Tang, H., Shi, L., Jin, L., Holmes, E. C., Ding, C., Zhu, T., & Zhang, Y.
Venue
The EMBO Journal
Published
2020-12-14
Volume
39
Issue
24
Pages
e105896-e105896
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3095186004
Cited by
187
References
35
FWCI
3.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage. https://app.cochat.ai/papers/10.15252/embj.2020105896
The paper
Chen, Y., Zheng, Y., Yu, Y., Wang, Y., Huang, Q., Qian, F., Sun, L., Song, Z., Chen, Z., Feng, J., An, Y., Yang, J., Su, Z., Sun, S., Dai, F., Chen, Q., Lu, Q., Li, P., Ling, Y., . . . Zhang, Y. (2020). Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage. The EMBO Journal. https://doi.org/10.15252/embj.2020105896

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.